Versant Capital Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.23M | Buy |
13,410
+1,849
| +16% | +$162K | 0.11% | 109 |
|
|
2026
Q1 | $985K | Buy |
11,561
+932
| +9% | +$83.1K | 0.1% | 123 |
|
|
2025
Q4 | $840K | Buy |
10,629
+8,590
| +421% | +$673K | 0.11% | 115 |
|
|
2025
Q3 | $163K | Sell |
2,039
-4,185
| -67% | -$357K | 0.02% | 536 |
|
|
2025
Q2 | $566K | Buy |
6,224
+164
| +3% | +$15K | 0.09% | 145 |
|
|
2025
Q1 | $568K | Buy |
6,060
+4,179
| +222% | +$374K | 0.1% | 129 |
|
|
2024
Q4 | $171K | Buy |
1,881
+465
| +33% | +$44.4K | 0.04% | 202 |
|
|
2024
Q3 | $147K | Buy |
1,416
+513
| +57% | +$52.3K | 0.03% | 185 |
|
|
2024
Q2 | $87.6K | Buy |
903
+523
| +138% | +$48.2K | 0.02% | 229 |
|
|
2024
Q1 | $34.2K | Sell |
380
-931
| -71% | -$78.9K | 0.01% | 358 |
|
|
2023
Q4 | $105K | Buy |
1,311
+29
| +2% | +$2.18K | 0.03% | 183 |
|
|
2023
Q3 | $91.2K | Sell |
1,282
-17
| -1% | -$1.27K | 0.03% | 189 |
|
|
2023
Q2 | $100K | Sell |
1,299
-100
| -7% | -$7.74K | 0.03% | 183 |
|
|
2023
Q1 | $105K | Buy |
1,399
+553
| +65% | +$41.1K | 0.04% | 167 |
|
|
2022
Q4 | $66.7K | Buy |
846
+17
| +2% | +$1.27K | 0.02% | 187 |
|
|
2022
Q3 | $58K | Buy |
829
+5
| +0.6% | +$392 | 0.02% | 191 |
|
|
2022
Q2 | $66K | Hold |
824
| – | – | 0.02% | 187 |
|
|
2022
Q1 | $62K | Sell |
824
-33
| -4% | -$2.61K | 0.02% | 216 |
|
|
2021
Q4 | $73K | Sell |
857
-20
| -2% | -$1.56K | 0.02% | 188 |
|
|
2021
Q3 | $66K | Sell |
877
-48
| -5% | -$3.81K | 0.02% | 186 |
|
|
2021
Q2 | $75K | Buy |
925
+10
| +1% | +$818 | 0.03% | 167 |
|
|
2021
Q1 | $72K | Sell |
915
-740
| -45% | -$58K | 0.03% | 187 |
|
|
2020
Q4 | $141K | Buy |
1,655
+3
| +0.2% | +$248 | 0.06% | 119 |
|
|
2020
Q3 | $127K | Buy |
1,652
+7
| +0.4% | +$534 | 0.06% | 125 |
|
|
2020
Q2 | $120K | Sell |
1,645
-15
| -0.9% | -$1.07K | 0.06% | 124 |
|
|
2020
Q1 | $110K | Sell |
1,660
-13
| -0.8% | -$917 | 0.06% | 122 |
|
|
2019
Q4 | $115K | Sell |
1,673
-144
| -8% | -$9.82K | 0.06% | 116 |
|
|
2019
Q3 | $133K | Hold |
1,817
| – | – | 0.06% | 102 |
|
|
2019
Q2 | $130K | Sell |
1,817
-194
| -10% | -$13.8K | 0.06% | 109 |
|
|
2019
Q1 | $137K | Sell |
2,011
-58
| -3% | -$3.75K | 0.06% | 114 |
|
|
2018
Q4 | $123K | Hold |
2,069
| – | – | 0.06% | 111 |
|
|
2018
Q3 | $138K | Sell |
2,069
-15
| -0.7% | -$999 | 0.06% | 117 |
|
|
2018
Q2 | $135K | Sell |
2,084
-65
| -3% | -$4.25K | 0.06% | 119 |
|
|
2018
Q1 | $154K | Sell |
2,149
-1,832
| -46% | -$132K | 0.06% | 112 |
|
|
2017
Q4 | $300K | Buy |
3,981
+2,757
| +225% | +$201K | 0.12% | 82 |
|
|
2017
Q3 | $89K | Sell |
1,224
-19
| -2% | -$1.37K | 0.05% | 154 |
|
|
2017
Q2 | $92K | Sell |
1,243
-7
| -0.6% | -$520 | 0.05% | 146 |
|
|
2017
Q1 | $91K | Hold |
1,250
| – | – | 0.05% | 147 |
|
|
2016
Q4 | $81K | Sell |
1,250
-418
| -25% | -$28.7K | 0.05% | 164 |
|
|
2016
Q3 | $123K | Buy |
1,668
+32
| +2% | +$2.37K | 0.07% | 112 |
|
|
2016
Q2 | $119K | Buy |
1,636
+19
| +1% | +$1.35K | 0.07% | 111 |
|
|
2016
Q1 | $114K | Buy |
1,617
+211
| +15% | +$14K | 0.07% | 110 |
|
|
2015
Q4 | $93K | Buy |
+1,406
| New | +$93.5K | 0.06% | 136 |
|
Other funds holding CL
SP
PAM
CIM
AAMU
EOJOAM
OIAM
AIM
Versant Capital Management's CL Position: Q2 2026 in Review
Versant Capital Management increased its Colgate-Palmolive (CL) stake by 16% in Q2 2026, buying an estimated $162K and bringing the position to 13,410 shares worth $1.23M. The position accounts for 0.11% of the portfolio, ranked #109.
Versant Capital Management first reported a position in CL in Q4 2015 and has held it in 43 quarters since. 333 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Versant Capital Management held 13,410 shares of Colgate-Palmolive worth $1.23M as of Q2 2026.
- Versant Capital Management bought 1,849 Colgate-Palmolive shares in Q2 2026, an estimated $162K.
- Colgate-Palmolive made up 0.11% of Versant Capital Management's portfolio in Q2 2026, its #109 holding.
- Versant Capital Management first reported a position in Colgate-Palmolive in Q4 2015 and has held it in 43 quarters since.
- 333 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.